2020 CONGRESS

National Pharmaceutical Congress XIV

Day 1: October 21, 2020 - 11:00 A.M. - 12:30 P.M.

Day 2: October 28, 2020- 11:00 A.M. - 12:30 P.M.

Day 3: November 4, 2020- 11:00 A.M. - 12:30 P.M.

Resources

NPC 14th Annual Pre Read 1 .jpg

Day 1 Pre-Read

NPC 14th Annual Agenda.jpg

Agenda

NPC 14th Annual Pre Read 2.jpg

Day 2 Pre-Read

NPC 14th Annual Faculty Bios.jpg

Faculty Bios

NPC 14th Annual Pre Read 3.jpg

Day 3 Pre-Read

NPC 14th Annual Post-Read.jpg

Executive Summary

Session 1 Introduction

Mitch Shannon
Chronicle Companies

Session 1: Career Advice in a Post Covid World

Jim Hall
Senior Vice President and General Manager,

Covis Pharma Canada

Arima Ventin
Executive Director,

Market Access, Pricing and Government Relations,

Allergan (an AbbVie Company)

Brian Canestraro
General Manager,

Intercept Pharmaceuticals

Session 1 Live Panel Discussion

Tiana DiMichele
Director, Business Development,

Impres Inc.

Session 2 Introduction

Mitch Shannon
Chronicle Companies

Session 2: How Do We Launch Projects Post Covid-19?

Ross Glover
General Manager,

Taiho Pharma Canada Inc.

Pat Forsythe
General Manager,

Eisai Inc.

David Renwick
Vice President and General Manager,

Emergent BioSolutions

Session 2 Live Panel Discussion

Karl Frank
Divisional Director,

Bayshore Specialty Rx.

 

Session 3 Introduction

Ben Parry
Pangaea Consultants

Session 3: Industry Roles and Partnerships: Have They Changed Through Covid-19?

Pamela Fralick
President,

Innovative Medicines Canada

Andrew Casey
President and CEO,

BIOTECanada

Dr. Jason Field
President and CEO,

Life Sciences Ontario

Brian Bloom
Founder,

Bloom Burton & Co

Session 3 Live Panel Discussion

Tony Volpe
Senior Director,

Shoppers Drug Mart Specialty Health Network

 

Session 4 Introduction

Ben Parry
Pangaea Consultants

Session 4: Patient-Centricity: What Does It Mean in Action?

Carol Stiff
Head of Canada,

Santen Canada Inc.

Zal Press
Vice-Chair,

CADTH Patient and Community Advisory Committee

Peter Brenders
CEO,

New Brunswick Health Research Foundation

Session 4 Live Panel Discussion

Stephanie Babbitt
Senior Director,

McKesson Specialty Health

 

Session 5 Introduction

Ben Parry
Pangaea Consultants

Session 5: Future External Deployments, Structures and Skill Sets

Sylvie Pilon
Former Vice-President, General Manager,

Lundbeck Canada

Paul Petrelli
General Manager,

Jazz Pharmaceuticals Canada

Ronnie Miller
President and CEO,

Roche Canada

Session 5 Live Panel Discussion

James Cran
President,

Pharma Consultants Inc.

 

Session 6 Introduction

Mitch Shannon
Chronicle Companies

Session 6: Where Are We With Respect to Inclusion and Diversity?

Danielle Portnik

Product Manager,

Mallinckrodt Pharmaceuticals

Healthcare Businesswomen's Association Toronto President

Marissa Poole
Country Lead, Sanofi Canada

General Manager, Sanofi Genzyme Canada

Eileen McMahon
Partner,

Torys LLP

Session 6 Live Panel Discussion

Dave Cann
Senior Director, Business Development

Ashfield Healthcare Canada

 

Closing Remarks

Mitch Shannon
Chronicle Companies